Amilie Boonstra1, Marieke Gielissen2, Eline van Dulmen-den Broeder3, Nicole Blijlevens1, Hans Knoop4,5, Jacqueline Loonen1. 1. Department of Hematology. 2. Department of Primary and Community Care, Radboud University Medical Center, Nijmegen. 3. Department of Pediatrics, Division of Oncology/Hematology, VU University Medical Center. 4. Department of Medical Psychology, Academic Medical Center (AMC), Amsterdam Public Health Research Institute, University of Amsterdam. 5. Department of Medical Psychology, Expert Center for Chronic Fatigue, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, the Netherlands.
Abstract
OBJECTIVES: Fatigue is a common and disabling late effect in childhood cancer survivors (CCS). In this pilot study, the effectiveness of cognitive behavior therapy (CBT) in CCS with persistent and severe fatigue was retrospectively evaluated. MATERIALS AND METHODS: In total, 33 consecutively referred CCS with persistent severe fatigue were offered CBT. The primary outcome was fatigue severity (Checklist Individual Strength, Fatigue Severity Subscale). Secondary outcomes were functional impairment, psychologic distress, and quality of life (QoL). RESULTS: In total, 25 CCS completed CBT (76%). The mean age of CCS was 23.1 years (range, 11 to 42 y), mean age at primary cancer diagnosis was 9.7 years (range, 0 to 17 y), and mean time since primary cancer diagnosis was 13 years (range, 5 to 34 y). Fatigue severity ([INCREMENT] 17.4; confidence interval (CI)=12.7-22.1; P<0.001), functional impairment (SIP8 [INCREMENT] 470.3; CI=312.3-628.4; P<0.001/SF36 [INCREMENT] 11.7; CI=17.2-6.3; P<0.001), and psychologic distress ([INCREMENT] 26.4; CI=15.6-34.9; P<0.001) were significantly decreased at second assessment. QoL ([INCREMENT] 13.5; CI=22.0-4.3; P=0.005) was significantly improved. A total of 23 CCS of the 33 CCS (70%) met the criteria for clinically significant improvement of fatigue. CONCLUSIONS: In this pilot study, the majority of severely fatigued CCS showed a clinically significant reduction in fatigue following CBT. Moreover, daily function and QoL improved, and psychologic distress decreased.
OBJECTIVES:Fatigue is a common and disabling late effect in childhood cancer survivors (CCS). In this pilot study, the effectiveness of cognitive behavior therapy (CBT) in CCS with persistent and severe fatigue was retrospectively evaluated. MATERIALS AND METHODS: In total, 33 consecutively referred CCS with persistent severe fatigue were offered CBT. The primary outcome was fatigue severity (Checklist Individual Strength, Fatigue Severity Subscale). Secondary outcomes were functional impairment, psychologic distress, and quality of life (QoL). RESULTS: In total, 25 CCS completed CBT (76%). The mean age of CCS was 23.1 years (range, 11 to 42 y), mean age at primary cancer diagnosis was 9.7 years (range, 0 to 17 y), and mean time since primary cancer diagnosis was 13 years (range, 5 to 34 y). Fatigue severity ([INCREMENT] 17.4; confidence interval (CI)=12.7-22.1; P<0.001), functional impairment (SIP8 [INCREMENT] 470.3; CI=312.3-628.4; P<0.001/SF36 [INCREMENT] 11.7; CI=17.2-6.3; P<0.001), and psychologic distress ([INCREMENT] 26.4; CI=15.6-34.9; P<0.001) were significantly decreased at second assessment. QoL ([INCREMENT] 13.5; CI=22.0-4.3; P=0.005) was significantly improved. A total of 23 CCS of the 33 CCS (70%) met the criteria for clinically significant improvement of fatigue. CONCLUSIONS: In this pilot study, the majority of severely fatigued CCS showed a clinically significant reduction in fatigue following CBT. Moreover, daily function and QoL improved, and psychologic distress decreased.
Authors: Adriaan Penson; Sylvia van Deuren; Ewald Bronkhorst; Ellen Keizer; Tom Heskes; Marieke J H Coenen; Judith G M Rosmalen; Wim J E Tissing; Helena J H van der Pal; Andrica C H de Vries; Marry M van den Heuvel-Eibrink; Sebastian Neggers; Birgitta A B Versluys; Marloes Louwerens; Margriet van der Heiden-van der Loo; Saskia M F Pluijm; Martha Grootenhuis; Nicole Blijlevens; Leontien C M Kremer; Eline van Dulmen-den Broeder; Hans Knoop; Jacqueline Loonen Journal: BMC Med Res Methodol Date: 2021-05-16 Impact factor: 4.615
Authors: Emma J Verwaaijen; Coriene E Catsman-Berrevoets; Heleen Maurice-Stam; Arianne B Dessens; Richelle Waslander; Tabitha P L van den Adel; Saskia M F Pluijm; Roel E Reddingius; Erna Michiels; Marry M van den Heuvel-Eibrink; Annelies Hartman Journal: Neurooncol Adv Date: 2021-11-03
Authors: Adriaan Penson; Iris Walraven; Ewald Bronkhorst; Heleen Maurice-Stam; Martha A Grootenhuis; Margriet Van der Heiden-van der Loo; Wim J E Tissing; Helena J H Van der Pal; Andrica C H De Vries; Dorine Bresters; Cécile Ronckers; Marry M Van den Heuvel; Sebastian J C M M Neggers; Birgitta A B Versluys; Marloes Louwerens; Saskia M F Pluijm; Leontien C M Kremer; Nicole Blijlevens; Eline Van Dulmen-den Broeder; Hans Knoop; Jacqueline Loonen Journal: Cancers (Basel) Date: 2022-06-09 Impact factor: 6.575
Authors: Sylvia van Deuren; Adriaan Penson; Eline van Dulmen-den Broeder; Martha A Grootenhuis; Margriet van der Heiden-van der Loo; Ewald Bronkhorst; Nicole M A Blijlevens; Nina Streefkerk; Jop C Teepen; Wim J E Tissing; Helena J H van der Pal; Marry M van den Heuvel-Eibrink; Birgitta A B Versluys; Dorine Bresters; Flora E van Leeuwen; Cécile M Ronckers; Leontien C M Kremer; Hans Knoop; Jacqueline J Loonen Journal: Cancer Date: 2021-11-01 Impact factor: 6.921
Authors: Salome Christen; Katharina Roser; Renée L Mulder; Anica Ilic; Hanne C Lie; Jacqueline J Loonen; Anneli V Mellblom; Leontien C M Kremer; Melissa M Hudson; Louis S Constine; Roderick Skinner; Katrin Scheinemann; Jordan Gilleland Marchak; Gisela Michel Journal: J Cancer Surviv Date: 2020-08-25 Impact factor: 4.442